Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Thyroid Medication Recalls

Recalls of levothyroxine and other thyroid hormone replacement drugs, often over sub-potency.

235 recalls in this category, newest first.

Class II · Moderate risk

Thyroid

Subpotent Drug

Ongoing Wrong potency / content Specialty Process Labs LLC NDC 81305-100-02 D-0294-2026
Class II · Moderate risk

Levothyroxine Sodium Tablets

Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.

Ongoing Labeling / mix-up Alvogen, Inc D-0259-2026
Class II · Moderate risk

Levothyroxine Sodium Tablets

Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.

Ongoing Wrong potency / content Accord Healthcare, INC. NDC 16729-450-15 D-0006-2026
Class II · Moderate risk

Levothyroxine Sodium Tablets

Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.

Terminated Impurity / degradation Lupin Pharmaceuticals Inc. NDC 68180-967-03 D-0167-2025